Rodman & Renshaw Conferences, LLC Company Profile

08:03 EDT 24th October 2014 | BioPortfolio


News Articles [354 Associated News Articles listed on BioPortfolio]

PharmAthene To Present At Rodman & Renshaw And Aegis Capital Corporation 2014 Investment Conferences

ANNAPOLIS, Md. , Sept. 8, 2014 /- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that E...

Rxi Pharmaceuticals Is Ready To Show The True Power of Its Technology Platform

Rxi Pharmaceuticals (RXII) will be presenting next Wednesday September 10th at the Rodman And Renshaw conference. Under normal circumstances conferences are no big deal as they just lay out what most ...

Oncothyreon to Present at Rodman & Renshaw Global Investment Conference

SEATTLE , Sept. 2, 2014 / Oncothyreon Inc. (Nasdaq: ONTY ) announced today that Robert Kirkman , M.D., President and Chief Executive Officer, will present at the Rodman & Renshaw 16 th A...

Synthetic Biologics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City

ROCKVILLE, Md. , Sept. 3, 2014 /-  Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious in...

Pharma-Bio Serv to Present at the Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014

Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that the Company will be a featured presenter at the Rodman & Renshaw ...

BioCryst to Present at Rodman & Renshaw Conference

RESEARCH TRIANGLE PARK, N.C., Sept. 3, 2014 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that its executives are scheduled to present a corporate summary and updat...

IntelGenx to Present at the Rodman & Renshaw Global Investment Conference

SAINT LAURENT, Quebec, Aug. 21, 2014 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx") today announced that Dr. Horst Zerbe, Chairman, President and Chief Executive Officer, ...

Cytomedix to Present at the Rodman & Renshaw Global Investment Conference

GAITHERSBURG, Md., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Cytomedix (OTC:CMXI), a pioneer in biodynamic therapies, today announced that Martin Rosendale, CEO, will present a corporate overview at the 16th...

Drugs and Medications [5 Associated Drugs and Medications listed on BioPortfolio]

Creon [Abbott Products, Inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON.CREON (pancrelipase) delayed-release capsules for oral useIni...

Pancreaze [Ortho-McNeil-Janssen Pharmaceutical, Inc.]

These highlights do not include all the information needed to use PANCREAZE™ safely and effectively. See full prescribing information for PANCREAZE™.  PANCREAZE™ (pancrelipase) delayed-release ...

Creon [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) capsule, delayed release for oral use I...

Pancrelipase [X-GEN Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use pancrelipase safely and effectively. See full prescribing information for pancrelipase. pancrelipase (pancrelipase) CAPSULE, DELAYED R...

Zenpep [Eurand Pharmaceuticals Inc.]

These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP (pancrelipase) delayed release capsules Initial U.S...

PubMed Articles [53 Associated PubMed Articles listed on BioPortfolio]

Health Conferences in Germany: An Overview.

Health conferences are a special management instrument of health policy. Less is known about the distribution. There is a lack of systematic evaluation methods.This overview is based on comprehensive ...

Communicating "Evidence": Lifestyle, Cancer and the Promise of a Disease-free Future.

In the era of evidence-based health care, conferences aimed at disseminating scientific knowledge perform an essential role in shaping policy and research agendas and transforming physician practice. ...

Implementation and evaluation of a multidisciplinary systems-focused internal medicine morbidity and mortality conference.

Morbidity and mortality (M&M) conferences provide a forum for discussing adverse events and systems-based practice (SBP) issues; however, few models for implementing multidisciplinary, systems-focused...

Reduced renshaw recurrent inhibition after neonatal sciatic nerve crush in rats.

Renshaw recurrent inhibition (RI) plays an important gated role in spinal motion circuit. Peripheral nerve injury is a common disease in clinic. Our current research was designed to investigate the ch...

Full-text publication of abstracts in emergency medicine in Denmark.

Abstracts presented at medical conferences or scientific meetings should ideally be published as full-text articles in peer-reviewed journals after initial presentation and feedback regardless of the ...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Healthy Lifestyles for People With Intellectual Disabilities

Relatively few health promotion and disease prevention programs have included or targeted people with disabilities, and even fewer have focused on individuals with intellectual disabilitie...

Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot Study

H pylori gastric infection is one of the most prevalent infectious diseases worldwide. The discovery that most upper gastrointestinal diseases are related to H pylori infection and therefo...

A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incontinence

A short presentation of a randomized clinical trial of biofeedback and anal injections as a first treatment option of faecal incontinence. Background: Faecal incontinence affects mainly w...

Companies [173 Associated Companies listed on BioPortfolio]

Rodman & Renshaw, LLC

Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM) is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC.

Rodman & Renshaw Conferences, LLC

Rodman & Renshaw, LLC Rodman & Renshaw, LLC and Cowen and Company acts as Exclusive Co-Placement Agents to Access Pharmaceuticals, Inc. in the Private Placement of $5.2 Million

Advaxis, Inc. and Rodman & Renshaw, LLC

Advaxis is a biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform tech...

Rodman Publishing

Rodman Publishing, based in Ramsey, New Jersey, has been a leading publisher of trade publications for more than four decades. Established in 1964, Rodman Publishing has been the leading source of inf...

More Information about "Rodman & Renshaw Conferences, LLC" on BioPortfolio

We have published hundreds of Rodman & Renshaw Conferences, LLC news stories on BioPortfolio along with dozens of Rodman & Renshaw Conferences, LLC Clinical Trials and PubMed Articles about Rodman & Renshaw Conferences, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rodman & Renshaw Conferences, LLC Companies in our database. You can also find out about relevant Rodman & Renshaw Conferences, LLC Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record